Online citations, reference lists, and bibliographies.
← Back to Search

Novel Nanosystems For The Treatment Of Ocular Inflammation: Current Paradigms And Future Research Directions

Lida Lalu, V. Tambe, Deepak Pradhan, K. Nayak, Suchandra Bagchi, Rahul Maheshwari, K. Kalia, Rakesh K Tekade
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
&NA; Ocular discomforts involve anterior/posterior‐segment diseases, symptomatic distress and associated inflammations and severe retinal disorders. Conventionally, the formulations such as eye drops, eye solutions, eye ointments and lotions, etc. were used as modalities to attain relief from such ocular discomforts. However, eye allows limited access to these traditional formulations due to its unique anatomical structure and dynamic ocular environment and therefore calls for improvement in disease intervention. To address these challenges, development of nanotechnology based nanomedicines and novel nanosystems (liposomes, cubosomes, polymeric and lipidic nanoparticles, nanoemulsions, spanlastics and nano micelles) are currently in progress (some of them are already marketed such as Eye‐logic liposomal eye spray@Naturalife, Ireland). Today, it is one of the central concept in designing more accessible formulations for deeper segments of the eyes. These nanosystems has largely enabled the availability of medicaments at required site in a required concentration without inversely affecting the eye tissues; and therefore, attaining the excessive considerations from the formulation scientists and pharmacologists worldwide. The entrapment of drugs, genes, and proteins inside these novel systems is the basis that works at the bio‐molecular level bestows greater potential to eradicate disease causatives. In this review, we highlighted the recent attempts of nanotechnology‐based systems for treating and managing various ocular ailments. The progress described herein may pave the way to new, highly effective and vital ocular nanosystems. Graphical abstract Figure. No caption available.
This paper references
10.1080/03639045.2017.1349787
New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment
Mengshuang Li (2017)
10.1089/JOP.2016.0085
A Rho-Associated Kinase Inhibitor Protects Permeability in a Cell Culture Model of Ocular Disease, and Reduces Aqueous Flare in Anterior Uveitis.
YamadaHiroshi (2017)
Nanoemulsion containing nonionic polymers, and uses especially in cosmetic, dermatological, pharmaceutical and / or ophthalmologic
L AlloretFlorence (2000)
10.1016/S0140-6736(04)17554-5
The eye in systemic inflammatory diseases
P. Mccluskey (2004)
Nanoemulsion containing nonionic polymers , and its uses
O. Aubrun-Sonneville (2006)
10.1515/9783111548050-024
M
M. Sankar (1824)
Polymeric triamcinolone acetonide nanoparticles as a new ACCEPTED MANUSCRIPT AC C EP TE D M AN U SC R IP T 69 alternative in the treatment of uveitis: in vitro and in vivo studies
A. Sabzevari (2013)
10.1016/j.geb.2003.09.006
Preparation
M. Voorneveld (2004)
10.1517/17425247.2015.1059419
Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis
Neslihan Üstündağ-Okur (2015)
Dendrimer
N. Mody (2014)
10.1016/j.yrtph.2016.10.020
Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion.
Bapi Gorain (2016)
10.2174/138161282130151007150300
Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders.
Rahul Maheshwari (2015)
10.1007/s12272-001-1266-6
Chitosan based nanocarriers for indomethacin ocular delivery
A. Badawi (2008)
10.1016/B978-0-08-101914-6.00004-1
Biopolymer-based nanocomposites for transdermal drug delivery
Rakesh K Tekade (2017)
10.1016/j.colsurfb.2016.04.054
PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.
E. Sánchez-López (2016)
10.1016/j.jconrel.2012.01.032
Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera.
P. Chopra (2012)
Nanotechnolgy A Novel Ocular Drug Delivery System
R. Devi (2017)
10.1016/j.biomaterials.2016.01.061
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.
Manju Kanamala (2016)
10.1016/j.jsps.2013.07.003
Design of liposomal colloidal systems for ocular delivery of ciprofloxacin.
E. Taha (2014)
10.1201/B19976-8
Nanotechnology for Pulmonary and Nasal Drug Delivery
Helene L. Dugas and Robert O. Williams (2016)
10.1007/s12272-013-0317-x
Formulation, in vitro and in vivo evaluation of lidocaine HCl ocular inserts for topical ocular anesthesia
Marwa Hassan Shukr (2014)
Nanoemulsion: concepts
Y. Singh (2017)
10.1039/C6RA17290C
Cationic bovine serum albumin (CBA) conjugated poly lactic-co-glycolic acid (PLGA) nanoparticles for extended delivery of methotrexate into brain tumors
P. Kesharwani (2016)
10.1136/bjo.63.1.45
Piloplex, a new long-acting pilocarpine polymer salt. A: Long-term study.
U. Ticho (1979)
10.35248/2684-1622.17.2.107
Novasorb ® Cationic Nanoemulsion and Latanoprost: The Ideal Combination for Glaucoma Management?
Philippe Daull (2017)
10.4028/www.scientific.net/SSP.222.159
Potential of Nanomaterials as Movers and Packers for Drug Molecules
Indu Pal Kaur (2014)
10.1016/j.ijpharm.2015.01.042
Evaluation of a newly developed HPMC ophthalmic insert with sustained release properties as a carrier for thermolabile therapeutics.
Arnout Everaert (2015)
10.1039/C7NJ00112F
A novel hydrogel with dual temperature and pH responsiveness based on a nanostructured lipid carrier as an ophthalmic delivery system: enhanced trans-corneal permeability and bioavailability of nepafenac
Shihui Yu (2017)
10.2174/1381612822666161027111957
Challenges and Future Prospects of Nanoemulsion as a Drug Delivery System.
M. N. Yukuyama (2017)
10.1080/17425247.2017.1264386
Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study
Rhythm Arora (2017)
10.1002/jbm.b.32871
Novel pluronic-chitosan micelle as an ocular delivery system.
Hong-Ru Lin (2013)
10.1208/aapsj0903044
Preparation and ocular pharmacokinetics of ganciclovir liposomes
Y. Shen (2008)
10.1016/S0939-6411(03)00187-5
Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use.
J. Vandervoort (2004)
10.1021/NN301873V
Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration.
H. Yang (2012)
10.1007/S10847-006-9253-4
Dexamethasone delivery to posterior segment of the eye
T. Loftsson (2007)
10.1016/J.JDDST.2016.01.008
Ocular inserts based on chitosan and brimonidine tartrate: Development, characterization and biocompatibility
Júlio Fernandes de Souza (2016)
10.1016/j.ijpharm.2017.03.005
Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies.
A. M. Al-mahallawi (2017)
10.1016/B978-0-08-100716-7.00027-1
Toxicity of nanostructured biomaterials
Rakesh K Tekade (2018)
10.1016/j.colsurfb.2013.11.029
Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers.
Liang Liu (2014)
10.1002/JPS.20685
Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration.
E. Vega (2006)
10.1016/j.ijpharm.2010.06.015
Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
L. Gan (2010)
Current Status of Nanotechnology Consumer Products and Nano-Safety Issues
N. Chuankrerkkul (2017)
10.1208/s12249-017-0771-8
Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation
D. Farghaly (2017)
Enhanced non invasive transtympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication
A. M. Al-mahallawi (2017)
10.1016/j.nano.2015.01.004
Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications.
H. Alvarado (2015)
10.1155/2013/858946
STAT6 siRNA Matrix-Loaded Gelatin Nanocarriers: Formulation, Characterization, and Ex Vivo Proof of Concept Using Adenocarcinoma Cells
Susanne R. Youngren (2013)
10.1016/j.ijpharm.2016.11.053
Pharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trends.
J. Rodríguez Villanueva (2017)
10.1089/jop.2015.0047
Recent Advances in Topical Ocular Drug Delivery.
V. Yellepeddi (2016)
10.1016/S1773-2247(11)50078-4
Microemulsions for ocular delivery: evaluation and characterization
F. Habib (2011)
10.1016/j.jsps.2011.10.001
Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment.
Rahul Maheshwari (2012)
10.1016/B978-0-12-809717-5.00010-5
Solid Lipid Nanoparticles for Targeting and Delivery of Drugs and Genes
Rakesh K Tekade (2017)
Proniosomederived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation
Q. Li (2014)
10.1016/j.jconrel.2017.01.012
Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
A. Mandal (2017)
10.1155/2012/604204
Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb
F. Lallemand (2012)
10.3109/21691401.2014.953633
Application of liposomes in medicine and drug delivery
H. Daraee (2016)
10.3109/10717544.2016.1138341
Preparation and in vitro/pharmacokinetic/pharmacodynamic evaluation of a slow-release nano-liposomal form of prednisolone
S. H. Hosseini (2016)
10.2147/IJN.S122747
A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride
Y. Huang (2017)
10.1007/s00281-014-0433-9
Autoimmune and autoinflammatory mechanisms in uveitis
R. Lee (2014)
10.14573/altex.1508241
Alternative methods for the replacement of eye irritation testing.
C. Lotz (2016)
10.1016/J.IJPHARM.2016.11.053
Pharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trends.
J. R. Villanueva (2017)
10.1016/B978-0-12-809717-5.00014-2
Carbon Nanotubes in Targeting and Delivery of Drugs
Rakesh K Tekade (2017)
10.1097/ICO.0000000000000825
Voriconazole-Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery
L. M. Andrade (2016)
10.1016/j.jcis.2015.02.011
Water-dilutable microemulsions for transepithelial ocular delivery of riboflavin phosphate.
N. Lidich (2016)
10.1080/10611860701453125
Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis
Khosro Adibkia (2007)
10.1016/J.IJPHARM.2005.05.036
Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate.
M. Yamaguchi (2005)
10.1016/j.ijbiomac.2016.10.035
Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.
Guoxin Tan (2017)
10.1007/978-3-319-47691-9_2
Anatomy of the Eye and Common Diseases Affecting the Eye
Emmanuel Addo (2016)
10.1002/wnan.65
Toxicity of nanomaterials to the eye.
T. Prow (2010)
10.1016/j.jconrel.2014.09.001
Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
N. S. Gandhi (2014)
10.1016/S0928-0987(02)00057-X
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
R. Pignatello (2002)
10.1016/j.nano.2017.02.007
Nano-ophthalmology: Applications and considerations.
M. A. Kamaleddin (2017)
10.1016/j.ijpharm.2012.07.024
Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes.
Takuya Fujisawa (2012)
10.1089/AIVT.2017.29011.RTL
Twenty-First Century In Vitro Toxicology Testing Methods and the Assessment of e-Cigarettes
John R. Fowle (2017)
M
A. A. Badawi (2008)
10.1007/978-3-319-29346-2_11
Nanovesicular Carrier Systems for Ophthalmic Drug Delivery
Lipika Chablani (2016)
10.1016/J.AJPS.2013.07.010
Development of liposomal formulations: From concept to clinical investigations
Yuchen Fan (2013)
10.1016/j.colsurfb.2010.07.029
Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
E. Gonzalez-Mira (2010)
10.1016/j.ijpharm.2009.05.028
Polyhydroxyethylaspartamide-based micelles for ocular drug delivery.
C. Civiale (2009)
10.3109/10717544.2014.943336
Liposomes in topical ophthalmic drug delivery: an update
R. Agarwal (2016)
10.1371/journal.pone.0095461
Bimatoprost-Loaded Ocular Inserts as Sustained Release Drug Delivery Systems for Glaucoma Treatment: In Vitro and In Vivo Evaluation
J. Franca (2014)
10.1089/jop.2012.0069
Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.
Ketan Hippalgaonkar (2013)
10.1016/j.ejpb.2016.10.010
Chitosan‐coupled solid lipid nanoparticles: Tuning nanostructure and mucoadhesion
G. Sandri (2017)
Compounds with trpv4 activity
D. Krizaj (2013)
10.1089/JOP.2015.0047
Recent Advances in Topical Ocular Drug Delivery.
Y. Kashyap (2016)
10.1016/j.ijpharm.2010.10.013
Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
Q. Luo (2011)
10.1016/j.xphs.2016.03.006
α-Lipoic Acid in Soluplus(®) Polymeric Nanomicelles for Ocular Treatment of Diabetes-Associated Corneal Diseases.
Fernando Alvarez-Rivera (2016)
10.1016/j.ijpharm.2011.04.027
Spanlastics--a novel nanovesicular carrier system for ocular delivery.
S. Kakkar (2011)
10.1016/j.ejps.2017.04.013
Nanoemulsion‐based electrolyte triggered in situ gel for ocular delivery of acetazolamide
N. Morsi (2017)
10.2174/1567201812666150224114751
Cubosomes: Innovative Nanostructures for Drug Delivery.
Aindrilla S Duttagupta (2016)
10.1016/j.exer.2016.11.010
Novel anti‐inflammatory liposomal formulation for the pre‐ocular tear film: In vitro and ex vivo functionality studies in corneal epithelial cells
Laura Soriano-Romaní (2017)
10.1021/bm4018879
Dithiol-PEG-PDLLA micelles: preparation and evaluation as potential topical ocular delivery vehicle.
Jian Yang (2014)
Original Research Paper FORMULATION AND EVALUATION OF OCULAR INSERTS OF ACYCLOVIR
Sharma Reshu (2013)
10.3109/17435390.2016.1153165
Safety and toxicity of nanomaterials for ocular drug delivery applications
N. Mehra (2016)
10.1016/j.yrtph.2017.01.009
The Isolated Chicken Eye test to replace the Draize test in rabbits
M. Prinsen (2017)
10.1021/acs.molpharmaceut.6b00445
Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage.
Shengyan Liu (2016)
10.1016/j.ejpb.2012.12.010
Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.
A. Sabzevari (2013)
10.1023/A:1018977130559
Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol
C. Losa (2004)
10.1158/1538-7445.AM2015-3680
Abstract 3680: Albumin-chitosan hybrid onconase nanocarriers for mesothelioma therapy
Rakesh K Tekade (2015)
10.1016/j.nano.2015.09.004
Nanostructured lipid carriers: Promising drug delivery systems for future clinics.
A. Beloqui (2016)
10.4103/2230-973X.177823
Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration
T. A. Abdullah (2016)
10.1166/SAM.2015.2245
Chitosan Encrusted Nonionic Surfactant Based Vesicular Formulation for Topical Administration of Ofloxacin
R. S. Maheshwari (2015)
10.1016/j.carbpol.2016.10.029
Gamma sterilization of diclofenac sodium loaded- N-trimethyl chitosan nanoparticles for ophthalmic use.
Rathapon Asasutjarit (2017)
10.1016/j.jcis.2016.07.020
Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles.
N. Soni (2016)
10.3109/10837450.2015.1125922
Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen
H. Almeida (2017)
Araci Bou- Chacra
M. Nishitani Yukuyama (2017)
Nanotechnolgy a Novel Ocular Drug Delivery : A Review
C. Kaur (2017)
10.2174/1573413711309010010
Nanoparticulate Carrier Mediated Intranasal Delivery of Insulin for the Restoration of Memory Signaling in Alzheimer’s Disease
Pankaj Dwivedi (2013)
10.1016/j.msec.2017.03.305
Comparison of electrospun and solvent cast polylactic acid (PLA)/poly(vinyl alcohol) (PVA) inserts as potential ocular drug delivery vehicles.
R. Bhattarai (2017)
10.1038/srep12968
Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation
Chuanlong Guo (2015)
10.1016/j.ijbiomac.2015.12.077
Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Mirza Salman Baig (2016)
10.1208/s12249-009-9373-4
Ciprofloxacin as Ocular Liposomal Hydrogel
K. Hosny (2009)
10.3109/08982104.2014.881850
Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone
Passent M E Gaafar (2014)
10.1007/s11095-014-1506-0
Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics
Rakesh K Tekade (2014)
10.1080/13602360500115095
Formulation
J. Peponis (2005)
10.2174/1381612823666170329150201
Recent Advances in Oncological Submissions of Dendrimer.
N. Soni (2017)
10.3109/02713680903261405
Cyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance and In Vivo Drug Release in Rabbit Eyes
E. Gökçe (2009)
10.1166/JNN.2016.10885
Nanomaterial Induced Immune Responses and Cytotoxicity.
A. Ali (2016)
10.1007/978-3-319-47691-9_9
Progress of Controlled Drug Delivery Systems in Topical Ophthalmology: Focus on Nano and Micro Drug Carriers
Ameeduzzafar Zafar (2016)
10.1111/j.1755-3768.2009.01584.x
Liposomes as an ocular delivery system of fluconazole: in‐vitro studies
F. Habib (2010)
10.1016/j.ijpharm.2013.07.002
Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation.
C. Luschmann (2013)
10.1038/aps.2010.98
Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability
S. Han (2010)
10.1016/J.REACTFUNCTPOLYM.2016.01.011
Mucoadhesion: A promising approach in drug delivery system
Shakir Mansuri (2016)
10.1016/j.ejps.2014.05.020
Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
Qi Li (2014)
Gabapentin compositions for treating or preventing ocular pain
C. Bucolo (2015)
10.2174/1381612821666150910113031
Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases.
Piyoosh A Sharma (2015)
10.1007/978-3-319-29346-2_10
Ocular Bioadhesives and Their Applications in Ophthalmic Drug Delivery
Rakesh K Tekade (2016)
10.1016/j.actbio.2016.02.041
Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery.
Tingting Xu (2016)
characterization and evaluation of novel elastic nano - sized niosomes ( ethonio - somes ) for ocular delivery of prednisolone
C. Rana
10.5935/0004-2749.20160010
Effects of prostaglandin analogs on blood flow velocity and resistance in the ophthalmic artery of rabbits.
Amália Turner Giannico (2016)
Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model
H. Liang (2012)
10.1016/j.ijpharm.2008.07.017
A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.
X. Li (2008)
10.1016/j.jconrel.2017.03.008
Nanoemulsion: Concepts, development and applications in drug delivery
Yuvraj Singh (2017)
Piloplex
U. Ticho (1979)
10.5958/0974-360X.2016.00189.X
Recent Advances in Ocular Drug Delivery Systems
Smita Nayak (2016)
10.1016/B978-0-12-809717-5.00001-4
Nanotechnology for the Development of Nanomedicine
Rakesh K Tekade (2017)
10.3109/10717544.2014.942811
Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle
A. Elmeshad (2016)
10.1208/s12249-014-0244-2
Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery
K. Cholkar (2014)
10.1016/j.drudis.2016.01.004
Cubosomes: remarkable drug delivery potential.
Z. Karami (2016)
10.1023/A:1016249812466
Evaluation of Poly(isobutylcyanoacrylate) Nanoparticles for Mucoadhesive Ocular Drug Delivery. I. Effect of Formulation Variables on Physicochemical Characteristics of Nanoparticles
S. K. Das (2004)
10.1016/j.ijbiomac.2016.04.070
Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
M. A. Kalam (2016)
10.1016/J.AJPS.2013.07.013
Preparation of bromfenac-loaded liposomes modified with chitosan for ophthalmic drug delivery and evaluation of physicochemical properties and drug release profile
Toshimasa Tsukamoto (2013)
Ophthalmic Nanoparticulate Formulation of a Cyclooxygenase-2 Selective Inhibitor
S. Panmai (2008)
Compositions for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye
A. S. Sawaya (2014)
10.3109/10717544.2013.858195
Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis
Nádia Silva (2015)
10.1016/j.ijpharm.2012.12.049
Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits.
S. Tayel (2013)
10.3109/02713683.2010.508867
In Vivo Evaluation of Novel Nanoparticles Containing Dexamethasone for Ocular Drug Delivery on Rabbit Eye
Farzaneh Rafie (2010)
10.1016/j.it.2015.04.003
Immune mechanisms in inflammatory and degenerative eye disease.
V. Perez (2015)
10.1016/j.msec.2016.10.017
A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.
L. Rathod (2017)
10.3109/1061186X.2012.723214
Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation
Y. Chen (2012)
10.1211/0022357044896
Development of a topical niosomal preparation of acetazolamide: preparation and evaluation
Deepika Aggarwal (2004)
10.3109/02652040902846883
Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery
E. Başaran (2010)
10.1515/9783111697888-007
E
Adam S. Opalski (1824)
10.4172/2155-9570.1000246
In vitro and In vivo Evaluation of Timolol Maleate Ocular Inserts Using Different Polymers
Mohamed Ali Attia Shafie (2012)
10.1016/j.ijpharm.2010.10.008
Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.
Jie Shen (2010)
10.1016/j.ijpharm.2015.07.010
Tri/tetra-block co-polymeric nanocarriers as a potential ocular delivery system of lornoxicam: in-vitro characterization, and in-vivo estimation of corneal permeation.
A. Salama (2015)
10.7324/JAPS.2016.60930
Fabrication and Evaluation of Ketorolac Loaded Cubosome for Ocular Drug Delivery
Zubair Ali (2016)
10.1016/j.jconrel.2016.08.024
Light activated liposomes: Functionality and prospects in ocular drug delivery.
T. Lajunen (2016)
10.3109/03639045.2015.1088867
Ocular delivery of cyanidin-3-glycoside in liposomes and its prevention of selenite-induced oxidative stress
J. Zhang (2016)
10.4155/CLI.14.135
Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence.
Philip Ames (2015)
10.1159/000431197
Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases.
E. Rodrigues (2016)
10.1089/jop.2013.0157
Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.
A. D. Vadlapudi (2014)
10.2217/nnm.16.19
Luteinizing hormone-releasing hormone peptide tethered nanoparticulate system for enhanced antitumoral efficacy of paclitaxel.
Raksha Ghanghoria (2016)
Compounds with trpv 4 activity , compositions and associated methods thereof
G. D. Prestwich D. Krizaj (2013)
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
A. J. Khopade (2016)
10.1007/978-3-319-25498-2
Pharmacology of Ocular Therapeutics
Thirumurthy Velpandian (2016)
Ophthalmic implant for delivering therapeutic substances
S. Erickson (2016)
Development and characterization of cyclosporine a loaded nanoparticles for ocular drug delivery: cellular toxicity
P. Aksungur (2011)
10.1016/j.ijpharm.2007.12.007
Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct.
A. Attama (2008)
10.1038/nature07201
Origin and physiological roles of inflammation
R. Medzhitov (2008)
10.2174/138920012800166535
Current methods and research progress in nanomaterials risk assessment.
Hongjun Lin (2012)
10.3109/02713683.2012.745879
Mucoadhesive Chitosan-Coated Cationic Microemulsion of Dexamethasone for Ocular Delivery: In Vitro and In Vivo Evaluation
K. Kesavan (2013)
10.1016/j.jconrel.2011.01.010
Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
P. Aksungur (2011)
Ocular Therapeutics: Eye on new Discoveries
T. Yorio (2011)
Promising ionsensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design
S. A. Tayel (2013)
10.1039/c2fo00005a
Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
Nissim Garti (2012)
10.1080/17425247.2016.1244187
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Héloïse Ragelle (2017)
10.1021/acs.biomac.6b00054
Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery.
Graeme Prosperi-Porta (2016)
10.3109/10717544.2014.923065
Colloidal drug delivery system: amplify the ocular delivery
Ameeduzzafar (2016)
10.1016/j.nbd.2015.12.017
Ocular inflammation induces trigeminal pain, peripheral and central neuroinflammatory mechanisms
Pierre-Serge Launay (2016)
10.1208/s12249-016-0589-9
Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate
O. A. Soliman (2016)
10.2147/IJN.S121642
Thermosensitive hydrogel based on chitosan and its derivatives containing medicated nanoparticles for transcorneal administration of 5-fluorouracil
A. Fabiano (2017)
10.1016/j.nano.2008.07.003
Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application.
Sagar M. Agnihotri (2009)
10.1089/jop.2014.0152
Development and evaluation of dexamethasone nanomicelles with potential for treating posterior uveitis after topical application.
S. Patel (2015)
10.2147/IJN.S129311
Multifunctional organic–inorganic hybrid nanoparticles and nanosheets based on chitosan derivative and layered double hydroxide: cellular uptake mechanism and application for topical ocular drug delivery
Huibo Chi (2017)
10.1089/JOP.2011.0176
Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole.
Indu Pal Kaur (2012)
Carboxyvinyl polymer-containing nanoparticle suspensions
M. A. Chowhan (2016)
Carboxyvinyl polymercontaining nanoparticle suspensions
M. A. Chowhan (2016)
Nanotechnology for ocular and otic drug delivery and targeting
A. A. Attama (2016)
10.1208/s12249-016-0575-2
Lipid Nanocarrier: an Efficient Approach Towards Ocular Delivery of Hydrophilic Drug (Valacyclovir)
R. Kumar (2016)
10.1208/s12249-017-0763-8
Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Jiayuan Huang (2017)
10.1089/JOP.2014.0152
Development and evaluation of dexamethasone nanomicelles with potential for treating posterior uveitis after topical application.
PatelSoohi (2015)
10.1016/0378-5173(94)90243-7
Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles
A. Zimmer (1994)
10.2174/1381612822666160813234723
A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
V. Andonova (2016)



This paper is referenced by
10.1039/c9sm01931f
Preparation and characterization of β-casein stabilized lipopeptide lyotropic liquid crystal nanoparticles for delivery of doxorubicin.
D. Wang (2019)
10.1016/j.ijpharm.2018.07.027
Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer
Shubhangi Mahajan (2018)
10.2217/nnm-2018-0297
Noninvasive biodegradable nanoparticles-in-nanofibers single-dose ocular insert: in vitro, ex vivo and in vivo evaluation.
I. Khalil (2019)
10.1080/10717544.2019.1568624
Ultra-small micelles based on polyoxyl 15 hydroxystearate for ocular delivery of myricetin: optimization, in vitro, and in vivo evaluation
Yuzhen Hou (2019)
10.1007/s13346-020-00810-8
Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies
Rakhee Kapadia (2020)
10.1080/10717544.2019.1609622
Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Alaa Emad Eldeeb (2019)
10.1016/j.ijpharm.2019.118979
Functional ibuprofen-loaded cationic nanoemulsion: development and optimization for dry eye disease treatment.
Bisera Jurišić Dukovski (2019)
10.2217/nnm-2017-0210
Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
Rahul Maheshwari (2017)
10.1007/978-3-030-17061-5_2
Bio-Based Nanoemulsion Formulations Applicable in Agriculture, Medicine, and Food Industry
Josef Jampílek (2019)
10.1080/17425247.2018.1496080
Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye
Y. Wang (2018)
10.35333/jrp.2020.142
Ocular delivery of natamycin based on monoolein/span 80/poloxamer 407 nanocarriers for the effectual treatment of fungal keratitis
Marzuka Shoeb Kazi (2020)
10.1007/978-3-319-70299-5_12
Nanotechnological Interventions for Drug Delivery in Eye Diseases
A. Ingle (2017)
10.1208/s12249-020-01699-9
Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment
Ameeduzzafar (2020)
10.3390/pharmaceutics12060570
Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation
R. Mazet (2020)
10.1016/J.MSEC.2019.110092
Hydrogels for diabetic eyes: Naltrexone loading, release profiles and cornea penetration.
Fernando Alvarez-Rivera (2019)
10.1007/978-1-4939-9516-5_13
Surface Modification of Biomedically Essential Nanoparticles Employing Polymer Coating.
Rahul Maheshwari (2019)
10.1007/978-1-4939-9516-5_9
Fabrication of Mucoadhesive-Dendrimers as Solid Dosage Forms.
Nidhi Raval (2019)
10.1016/j.ejphar.2020.173208
Neuroprotection: A versatile approach to combat glaucoma.
S. Naik (2020)
10.1016/j.drudis.2019.05.006
Therapeutic implications of nanomedicine for ocular drug delivery.
Tuo Meng (2019)
Semantic Scholar Logo Some data provided by SemanticScholar